Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by HighSkies2019on Sep 09, 2021 9:36am
141 Views
Post# 33830465

Fellow Investors !!!

Fellow Investors !!!I know that Angelal means well with their post ...it was in their own opinion about future forecast...they did not say it was fact ..it was because they believed in the products and had things rolled out accordingly they could very well be in line with their predictions ..they offer valuable insight ..not all will agree and thats why this board is open to everyone's thoughts .. .as for GVHD many thought it had great potential and I still do ..until I see it confirmed from the company the end result .. I have never saw a post that they stated FDA approved....but we all had the same expectations hopes for FDA accelerated ..when covid hit R107 we were fortunate to have a connection and it became our front runner ...now let's see what the company has done for us ... I slur towards my fellow long peers from time to time ...its only because they come as a group from other certain boards... they come off smug with posts towards their fellow long peers mocking them because their peers were expressing their thoughts or concerns in a post ...on their boards they kick investors out that don't agree with them...and thats ok its their board ...but now you have some investors that will feel the intimidation and not speak out or ask questions and only agree just so not to cause conflict in the group .....I stepped back a long time ago ..truth is this is my only stk in my portfolio I have ever posted on but prefer a board open to all ...but will always be honest and open with my post good or bad even at times ridiculous ..sometimes we find things out and even learn from others post ...but as long as I am on this stk will support my fellow long peers when I know we all want success for a product that could change the coarse of a human life.....whether we agree or not ... gltal
<< Previous
Bullboard Posts
Next >>